Global Fractional Flow Reserve Market Growth (Status and Outlook) 2023-2029

Global Fractional Flow Reserve Market Growth (Status and Outlook) 2023-2029

Fractional flow reserve (FFR) is a technique used in coronary catheterization to measure pressure differences across a coronary artery stenosis (narrowing, usually due to atherosclerosis) to determine the likelihood that the stenosis impedes oxygen delivery to the heart muscle (myocardial ischemia). FFR is a novel and potentially clinically useful mathematical solution for estimation of stenotic coronary artery atherosclerosis. Reliability/collaborative measurement between capable laboratories in measuring this essential metric appears muddled in a proprietary race to claim cardiac mathematics dedicated to risk in ischemic cardiac disease. Proprietary claims of cardiac mathematics have not been previously argued in patent law. Fractional flow reserve is defined as the pressure after (distal to) a stenosis relative to the pressure before the stenosis. The result is an absolute number; an FFR of 0.80 means that a given stenosis causes a 20% drop in blood pressure. In other words, FFR expresses the maximal flow down a vessel in the presence of a stenosis compared to the maximal flow in the hypothetical absence of the stenosis. This report studies the device for Fractional Flow Reserve.
LPI (LP Information)' newest research report, the “Fractional Flow Reserve Industry Forecast” looks at past sales and reviews total world Fractional Flow Reserve sales in 2022, providing a comprehensive analysis by region and market sector of projected Fractional Flow Reserve sales for 2023 through 2029. With Fractional Flow Reserve sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Fractional Flow Reserve industry.
This Insight Report provides a comprehensive analysis of the global Fractional Flow Reserve landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Fractional Flow Reserve portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Fractional Flow Reserve market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Fractional Flow Reserve and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Fractional Flow Reserve.
The global Fractional Flow Reserve market size is projected to grow from US$ 794.3 million in 2022 to US$ 1648.8 million in 2029; it is expected to grow at a CAGR of 11.0% from 2023 to 2029.
Global Fractional Flow Reserve key players include Philips, Abbott, Boston Scientific, Bracco, Opsens, etc. Global top five manufacturers hold a share about 95%. North America is the largest market, with a share about 45%, followed by Europe, with a share about 25 percent. In terms of application, the largest application is Multi-vessel disease, followed by Single-vessel disease.
This report presents a comprehensive overview, market shares, and growth opportunities of Fractional Flow Reserve market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Type I
Type II
Segmentation by application
Multi-vessel Disease
Single-vessel Disease
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Philips
Abbott
Boston Scientific
Bracco
Opsens

Please note: The report will take approximately 2 business days to prepare and deliver.